CH Biotech R&D Co., Ltd. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was TWD 879.780 million compared to TWD 780.960 million a year ago. Operating income was TWD 368.465 million compared to TWD 377.655 million a year ago. Net income was TWD 285.422 million compared to TWD 290.325 million a year ago. Basic earnings per share was TWD 4.77 compared to TWD 5.05 a year ago. Diluted earnings per share was TWD 4.7 compared to TWD 4.97 a year ago.